Decipher Urologic Cancers
GenomeDx is transforming patient management by putting usable genomic information in the hands of physicians and their patients. GenomeDx has developed the Decipher® Prostate and Bladder Cancer Classifier tests, genomic tests that provide treatment information for urologic cancer patients.